MDMA

Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Psychedelics Therapy For Military Veterans In MA, Clinical Research Of Psilocybin In AZ And More
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Psychedelics Therapy For Military Veterans In MA, Clinical Research Of Psilocybin In AZ And More
FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD
New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia

MDMA Recent News

War And Drugs: Ukraine And Russian Soldiers Use MDMA, Amphetamines, Alcohol And Cannabis As Healing And Combat Tools
Discover how soldiers in Ukraine and Russia use MDMA, amphetamines, alcohol, and cannabis to cope with combat stress and trauma.
Those Who Have Tried And Had Mostly Positive Experiences With Marijuana Or Psychedelics More Likely To Support Legalization, New Survey
NJ Activists Plant Cannabis Garden On State House Lawn, Fentanyl Replaces MDMA In Fed Drug Testing, Psychedelics Therapy For Vets
NJ activists defy laws with a cannabis garden, Congress advocates MDMA therapy for vets, and fentanyl replaces MDMA in federal tests. Read!
Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application
Three Key Takeaways:
Veterans Affairs, After Decades, Will Fund Psychedelic Research For Vets With PTSD And Depression
In a groundbreaking move, the U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among military veterans.
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Pub
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024.
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
Studies and reports from the U.S. Department of Veterans Affairs (VA) and other research publications suggest that an estimated 20-30% of U.S.
Payton Nyquvest On Off-Label Markets
In this episode of The Dales Report, we’re sitting down with Numinus Wellness CEO Payton Nyquvest for a psychedelic exclusive. Our topic of conversation with Payton today steers into the recent FDA warning and the dynamic world of off-label markets for new compounds.
Legal Psychedelics: Which Compounds Will Be Approved Next? MDMA, LSD Or Something Else?
This article was originally published on Microdose and appears here with permission.
Shrooms Legalized Before Weed? FDA Posts Guidelines To Research Psychedelics
This article was originally published on Cannabis.net and appears here with permission.
Is It Safe For Older People To Take Psychedelics? Here's What The Research Says
This article was originally published on Psychedelic Spotlight and appears here with permission. 
Shandraw On What To Expect At Upcoming MAPS Conference
Johns Hopkins University Put Octopuses In MDMA-Laced Waters: 'They Were Essentially Hugging'
This article was originally published on Psychedelic Spotlight and appears here with permission. In the Netflix documentary "My Octopus Teacher," filmmaker Craig Foster befriends an octopus in the Atlantic waters near his home. Over a year, he visits her nearly every day.
EXCLUSIVE: Infrastructure Built For Healing: 'Consolidation And Legitimacy Are Crucial For Psychedelic Industry Growth'
“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastructure for upcoming FDA-approved therapies,” said Daniel Carcillo, founder and CEO at Wesana Health Holdings Inc (OTCQB:
Australian Health Authority To Allow Psilocybin And MDMA Assisted Therapy For Depression, PTSD
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.
Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission.
Potential For MDMA Assisted Therapy Approval Boosts Psychedelic Stocks Early In 2023
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales, lead financial writer Benjamin A. Smith and TDR contributor Anthony Varrell give their macro outlook in the cannabis, crypto and psychedelic sectors—the latter boosted early year on the promise of regulatory approval of services (MDMA).
Treating Postpartum Depression With Cannabis Or Psychedelics Like Ketamine And MDMA: Does It Work?
This article was originally published on Psychedelic Spotlight and appears here with permission. Postpartum depression impacts thousands with no good treatment options. Some people are now treating postpartum depression with psychedelics
Breaking Down Molly: Swiss University Studies How MDMA's Components Might Affect Humans
MindMed’s (NASDAQ: MNMD) recurring collaborator, Prof. Dr.
Australia Update: Victoria Officials Seek To Ban Federal Psychedelic Medicine Permits
In Victoria, Australian health officials are proposing to restrict permits currently allowing patients with mental illnesses to access psychedelics in a therapeutic framework back to research and clinical trials “app
Big Day In Congress: Psychedelics & Cannabis Research Amendments Approved As Part Of Must-Pass Defense Bill
The House of Representatives approved two psychedelics research amendments and a measure requiring a military study into cannabis-related enforcement discrimination in the armed services, reported Marijuana Moment.
A Brief History Of MDMA: From The CIA To Raves To Psychedelic Therapy
This article was originally published on Psychedelic Spotlight and appears here with permission. Today, MDMA is one of the world’s most-well known drugs. Famous as a party drug prevalent among concertgoers, the compound is also growing in popularity as a therapy-enhancing medicine.